HiRM Retreat 2026

Dr. Heng presented, "The miR-362-3p/BCLAF1 axis regulates cisplatin sensitivity and metastatic progression in triple-negative breast cancer"  at the HiRM Retreat today.

She hopes colleagues will be inspired to use the highly-sensitive miRNA screening assays at the Detection Unit, PRM Core that she directs.